Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2025-09-22 00:00:00 ET · period of report 2025-09-19 · accession 0001214659-25-014009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-22 | 2025-09-19 | AQST | Barber Daniel | Pres, CEO, Dir | S - Sale | $6.00 | -400 | 1.01M | -0.0% | -$2,400 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-19 | S | D | 400 | $6.00 | 1,014,773 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. |